Future of Surgery: Pitch Competition
September 21, 2017
B. Braun supplies the global healthcare market with products for anesthesia, intensive medicine, cardiology, extra corporeal blood treatment, and surgery, as well as services for hospitals, general practitioners, and the homecare sector.
Join B. Braun and the German Accelerator Life Sciences for a Pitch Competition on the Future of Surgery on September 21, 2017, at Venture Cafe Kendall.
Five (5) medical device start-ups will be selected to pitch a panel of experts. Prizes will be awarded to two teams:
The 1st Place prize is $2,000 in cash OR a mentoring day with senior executives at the B. Braun North America headquarters in Pennsylvania.
The 2nd Place prize includes a $1,000 cash prize.
APPLY TO PITCH!
To apply for the competition, please send a one-pager to email@example.com. The application deadline is September 13, 2017.
Meet the Judges
Caroll H. Neubauer
Eric J. Evans
Mass Medical Angels & Launchpad Ventures
Azia Capital Partners
McGeever & SalesForce4Hire
InfiniteMD & Recon Therapeutics
Book Special Office Hours with B. Braun
David E. Banko
Director, Health Economics and Outcomes Research, B. Braun Medical
Mr. Banko is Director, Health Economics and Outcomes Research at B. Braun Medical Inc. located in Bethlehem, Pennsylvania. He is responsible for identifying strategies to leverage health economics and outcomes studies across the breadth of B. Braun’s portfolio resulting in the differentiation of their products in a highly competitive market. Mr. Banko partners with all levels of the Organization to develop an optimized evidence generation plan ensuring widespread adoption of their innovative products upon commercialization. Mr. Banko is leading B. Braun Medical Inc in preparing for the challenges and opportunities associated with the transition to a value oriented healthcare system in the United States.
Mr. Banko brings over 20-years of medical device, diagnostics and hospital finance experience to B. Braun Medical Inc. Most recently, he spent 12 years working with two operating companies that were part of the Johnson & Johnson family of companies. During his time with J&J, he successfully leveraged outcomes evidence to shape Medicare’s National medical coverage and reimbursement policies and developed programs to assist hospitals and physicians in securing market access from Medicare and other third-party payors for FDA approved emerging medical device technologies.
He has lead efforts in developing responses to payer’s Health Technology Assessments (HTAs) and in educating internal business partners on the implications of major policy shifts such as Medicare’s bundled payment initiatives, comparative (cost) effectiveness and gainsharing. Mr. Banko gained extensive experience in health care finance and reimbursement working with healthcare systems in Northeastern Pennsylvania.
He received a B.S. degree in Liberal Studies from the University of Scranton and an M.S. degree in Finance from King’s College. Mr. Banko is a Certified Public Accountant, licensed in the State of Pennsylvania.
Robert C. Spiro, PhD
Sr. Vice President of Biologics, Development, Scientific & Clinical Affairs, Aesculap Biologics (a B. Braun Company)
In collaboration with: